Zacks Sell List Highlights: Safety Insurance Group, Endurance Specialty Holdings, China Shengda Packaging Group and MAKO Surgica

   Zacks Sell List Highlights: Safety Insurance Group, Endurance Specialty
          Holdings, China Shengda Packaging Group and MAKO Surgical

  PR Newswire

  CHICAGO, June 7, 2011

CHICAGO, June 7, 2011 /PRNewswire/ -- Zacks.com releases details on a group of
stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks
to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong
Sell): Safety Insurance Group, Inc. (Nasdaq: SAFT ) and Endurance Specialty
Holdings Ltd. (NYSE: ENH ). Further, Zacks announced #4 Rankings (Sell) on two
other widely held stocks: China Shengda Packaging Group Inc. (Nasdaq: CPGI )
and MAKO Surgical Corp. (Nasdaq: MAKO ). To see the full Zacks #5 Rank List -
Stocks to Sell Now visit : http://at.zacks.com/?id=92

(Logo:  http://photos.prnewswire.com/prnh/20101027/ZIRLOGO )

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List
of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall
Street continued to tout stocks during the market declines of the last few
years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why SAFT and ENH have a Zacks Rank of #5 (Strong Sell)
and should most likely be sold or avoided for the next one to three months.
Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the
Zacks Rank universe:

Safety Insurance Group, Inc. (Nasdaq: SAFT ) announced first -quarter loss of
23 cents per share on May 4 that missed analysts' expectations by 133%. This
apart the earnings also missed the previous year's results by 69%. The Zacks
Consensus Estimate for the current year slipped 35 cents to $3.02 per share in
the last 60 days. Next year's estimate dipped a couple of cents to $3.29 per
share in that time span.

Endurance Specialty Holdings Ltd. (NYSE: ENH ) posted a first-quarter loss of
$2.42 per share on May 2, which came in 18 cents wider than the average
forecast. The diluted earnings per share fell 147% to a loss of $2.25 on March
2011 as compared to results of March 2010. The Zacks Consensus Estimate for
the full year fell $1.17 per share to a profit of 49 cents per share over the
past month reflecting cuts by all the 7 covering analysts. For 2012, analysts
expect a profit of $5.00 per share, compared to projections of a profit of
$5.03 per share in a span of 7 days. 

Here is a synopsis of why CPGI and MAKO have a Zacks Rank of 4 (Sell) and
should also most likely be sold or avoided for the next one to three months.
Note that a #4 Sell rating is applied to 15% of all the stocks ranked by
Zacks;

China Shengda Packaging Group Inc. 's (Nasdaq: CPGI ) first-quarter earnings
of 9 cents per share, posted on May 13, lagged analysts' projections by nearly
36%. For 2011, the Zacks Consensus Estimate moved down 26 cents to a profit of
32 cents per share in the last 30 days as both the covering analysts cut back
on forecasts. Estimate for next year slid 37 cents to a profit of 41 cents per
share during the same time span.

MAKO Surgical Corp. (Nasdaq: MAKO ) reported a first-quarter loss of 27 cents
per share on May 3, that fell 12% short of the Zacks Consensus Estimate. The
full-year average forecast is currently pegged at a loss of 83 cents per
share, compared to projections of a loss of 81 cents per share made 30 days
back. Next year's forecast dropped 1 cent to a loss of 33 cents per share in
the same period.

Truly taking advantage of the Zacks Rank requires the understanding of how it
works. The free special report; "Zacks Rank Guide: Harnessing the Power of
Earnings Estimate Revisions" is available to provide this insightful
background. Download a free copy now to prosper in the years to come at
http://at.zacks.com/?id=93

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are
the most powerful force impacting stock prices." Since inception in 1988, #1
Rank Stocks have generated an average annual return of +28%. During the
2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500
tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong
Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since
1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (2.8%
versus +9.7%). Thus, the Zacks Rank system allows investors to truly manage
portfolio trading effectively.

Visit http://www.zacks.com/performance for information about the performance
numbers displayed in this press release.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of
Zacks Rank Buy stocks and highlights those stocks poised to outperform the
market. Subscribe to this free newsletter today by visiting
http://at.zacks.com/?id=94

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed
in 1978 by Len Zacks. As a PhD from MIT Len knew he could find patterns in
stock market data that would lead to superior investment results. Amongst his
many accomplishments was the formation of his proprietary stock picking
system; the Zacks Rank, which continues to outperform the market by nearly a 3
to 1 margin. The best way to unlock the profitable stock recommendations and
market insights of Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow of
Profitable ideas GUARANTEED to be worth your time! Register for your free
subscription to Profit from the Pros at http://at.zacks.com/?id=95

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch 

Zacks Investment Research is under common control with affiliated entities
(including a broker-dealer and an investment adviser), which may engage in
transactions involving the foregoing securities for the clients of such
affiliates.

Disclaimer: Past performance does not guarantee future results. Investors
should always research companies and securities before making any investments.
Nothing herein should be construed as an offer or solicitation to buy or sell
any security.

Media ContactZacks Investment Research800-767-3771 ext. 9339 support@zacks.com
http://www.zacks.com

SOURCE Zacks Investment Research, Inc.

Website: http://www.zacks.com
 
Press spacebar to pause and continue. Press esc to stop.